Jinsy A. Andrews

Neurology
710 W 168th St
New York, NY 10032

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications

Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis.

Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis.

Journal: JAMA neurology
Published: February 09, 2026

Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paper.

Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paper.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: December 09, 2025

Exploring the Lived Experiences of Individuals with Amyotrophic Lateral Sclerosis (ALS): A Qualitative Study and Conceptual Model of Signs, Symptoms, and Functional Impacts.

Exploring the Lived Experiences of Individuals with Amyotrophic Lateral Sclerosis (ALS): A Qualitative Study and Conceptual Model of Signs, Symptoms, and Functional Impacts.

Journal: Neurology and therapy
Published: October 06, 2025

Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALS.

Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALS.

Journal: Biomedicines
Published: September 18, 2025

Toward therapeutic trials in primary lateral sclerosis.

Toward therapeutic trials in primary lateral sclerosis.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: July 06, 2025

Startle Reflex in Primary Lateral Sclerosis (PLS): A Comparison With Amyotrophic Lateral Sclerosis (ALS).

Startle Reflex in Primary Lateral Sclerosis (PLS): A Comparison With Amyotrophic Lateral Sclerosis (ALS).

Journal: Muscle & nerve
Published: June 27, 2025

Hospitalizations as an outcome measure in COURAGE-ALS.

Hospitalizations as an outcome measure in COURAGE-ALS.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: June 12, 2025

A Modeling Investigation of the CYP1A Drug Interactions of Riluzole.

A Modeling Investigation of the CYP1A Drug Interactions of Riluzole.

Journal: Clinical and translational science
Published: May 25, 2025

Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial.

Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial.

Journal: JAMA neurology
Published: March 24, 2025

CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

Journal: JAMA
Published: March 11, 2025

Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

Journal: JAMA
Published: March 11, 2025

Placebo-Controlled, Randomized Double-Blind N-Of-1 Trial to Study Safety and Potential Efficacy of TJ-68 for Improving Muscle Cramps in Patients With Amyotrophic Lateral Sclerosis: A Pilot Study.

Placebo-Controlled, Randomized Double-Blind N-Of-1 Trial to Study Safety and Potential Efficacy of TJ-68 for Improving Muscle Cramps in Patients With Amyotrophic Lateral Sclerosis: A Pilot Study.

Journal: Muscle & nerve
Published: February 18, 2025
Showing 1-12 of 61

Last Updated: 09/26/2026